Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Bionano Genomics, Inc. (BNGO) had Weighted-Average Shares Outstanding (Diluted) of 2.69M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$6.46M |
|
$-3.10M |
|
$3.52M |
|
$2.94M |
|
$14.92M |
|
$-8.46M |
|
$5.37M |
|
$-3.10M |
|
$-3.10M |
|
$-3.10M |
|
$-3.10M |
|
$-3.10M |
|
$-3.10M |
|
$-8.46M |
|
$-6.22M |
|
2.69M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
2.69M |
$-1.15 |
|
$-1.15 |
|
| Balance Sheet Financials | |
$44.93M |
|
$18.34M |
|
$33.48M |
|
$78.41M |
|
$26.41M |
|
$3.53M |
|
$3.82M |
|
$30.23M |
|
$48.19M |
|
$39.82M |
|
$48.19M |
|
3.10M |
|
| Cash Flow Statement Financials | |
$-2.76M |
|
$-14.07M |
|
$10.89M |
|
$9.57M |
|
$3.62M |
|
$-5.95M |
|
$1.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.70 |
|
-- |
|
-- |
|
0.07 |
|
0.35 |
|
45.50% |
|
-131.10% |
|
-131.10% |
|
-- |
|
-47.93% |
|
-48.04% |
|
$-2.76M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.37 |
|
1.93 |
|
46.75 |
|
-6.44% |
|
-7.79% |
|
-3.96% |
|
-6.00% |
|
$15.54 |
|
$-1.03 |
|
$-1.03 |
|